Objective Surgical antimicrobial prophylaxis (SAP) is a method proved to be effective in reducing the risk of surgical site infections (SSI). Although there are numerous international and local Guidelines, SAP is often performed inappropriately. The monitoring that was carried out at the Surgery Clinic of the University Hospital "Tsaritsa Yoanna -ISUL" in August 2008 showed a high level of inappropriately performed SAP. In order to optimize SAP, a Local Guideline (LG) for SAP was developed.
INTRODUCTION
SSI are an important cause of morbidity and mortality and are associated with the increased costs to health care providers [1] [2] [3] [4] . According to the Centers for Disease Control and Prevention (CDC), SSI accounted for about 31% of nosocomial infections in the United States in 2010 [5] . An overall incidence of SSI for the intra-abdominal infections ranges from 10% to 18% [6, 7] . It is widely known fact, however, that AMAs are administered inappropriately in as much as 50% of cases [8] . Errors in antimicrobial prophylaxis for surgical patients remain one of the most frequent types of preventable medication errors in hospitals [9] .
The foundations of modern SAP in surgical practice were set in 1960s and 1970s by Burke [10] , Polk and Lopez-Mayor [11] and Stone et al. [12] . Irrespective of the great number of international, national and local consensuses, guidelines and published articles [13] [14] [15] [16] [17] [18] , SAP is still inappropriately performed in not a small percentage of the cases [19, 20] . It has been found that direct implementation of "foreign" guidelines is relatively low effective mainly because of the insufficient compliance by the medical staff. A multicenter study in the Netherlands has found out that an overall adherence to the respective guidelines is 28% and the compliance regarding key parameters of SAP ranges from 43% to 92% [21] . Similar results have been seen in the assessment of SAP in Turkey [22] . In this context, it is important to identify and address the factors leading to low compliance which most often are [23] :
Insufficient awareness of physicians related to the principles of rational prophylaxis and the comparative efficiency of the individual AMA; No introduced restrictive measures as re gards the prescription of AMA as well as no ongoing monitoring of AMA use; Disagreement by the medical staff with specific aspects of the respective guidelines; No incentives to the medical staff; Influence by the pharmaceutical industry.
In August 2008, a monitoring was carried out at the Surgery Clinic of the University Hospital "Tsaritsa Yoanna -ISUL" that showed a high level of inappropriately performed SAP. The main problems in this regard were found to be as follows: start of AMA administration for the purposes of SAP -more than 24 hours prior to or after the end of surgical intervention; length of AMA administration -usually more than 72 hours and often until patients are discharged from the Clinic; irrational selection of AMA.
In practice, regardless of the instructions about the performance of SAP available at the Hospital, they were not followed and remained on paper only. In order to address this problem in September 2008 using an interdisciplinary approach with the leading role of clinical pharmacologists and active involvement of the Management of the Surgery Clinic, a LG for SAP was developed and implemented. The aim was an upgrading of the level of appropriate performance of SAP to the extent complying with the world standards and consequent cost savings for the Surgery Clinic as well.
METHODS
The Surgery Clinic of the University Hospital "Tsaritsa Yoanna -ISUL" is a general surgery clinic with 30 beds with prevailing abdominal pathology.
LG for SAP was developed on the basis of internationally accepted standards for SAP, including motivated selection of AMA, route, time, and length of administration [13] [14] [15] [16] [17] [18] . In developing the LG for SAP the specifics of the Hospital were also considered such as:
prevailing surgical interventions at the Clinic; local antibiotic resistance; drug list of the Hospital; considerations of the Surgery Clinic Management as regards the manner of performance of SAP based on their longtime experience; financial capacity of the Hospital.
Surgical interventions where the performance of SAP is mandatory (e.g., hemicolectomy, appendectomy, etc.) as well as surgeries where SAP is not to be performed (e.g., herniotomy without mesh insertion) were specified in the LG. Selecting an AMA (or a combination of AMA) for the purposes of SAP was based on the following requirements:
AMA must have a spectrum consistent with the most common causes of SSI in the specific surgical interventions;
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In the prevailing part of surgical interventions, LG provides preoperative (30-60 minutes prior to the surgical intervention) intravenous administration of a single dose of the respective AMA. According to LG, the second dose of AMA should be administered when there are extra risk factors such as: surgery duration >3 hours, blood loss >1.5 L, infusion of fluids >15 mL/kg/weight as well as in development of intra-operative complications. In strictly specified surgical interventions (e.g., gastric, colon, or extra-hepatic bile duct cancer) in high-risk patients, LG allows for extension of SAP length for up to 48 hours in the discretion of the surgical team.
Four approaches such as training, restriction, monitoring, and feedback were used in the implementation of LG into the clinical practice.
The training of the medical staff at the Surgery Clinic was carried out by clinical pharmacologists in the form of lectures, seminars and discussions. The aim was to update the surgical teams on the set goals, the expected results as well as direct benefits both for the patients (increased efficacy and safety) and the hospital (improvement of medical care to patients and saving resources).
The restriction was performed by introduction of strict rules of prescribing AMA for the purposes of SAP. In addition, the clinical pharmacologists carried out monitoring of the promotional activities of pharmaceutical companies at the Surgery Clinic in order to limit the use of cost-ineffective AMA.
The monitoring of SAP was performed by clinical pharmacologists through the monthly retrospective review of the medical records of patients that have undergone surgery at the Clinic during the respective month. For that purpose, the specific SAP checklists were designed allowing quick and accurate assessment of SAP performed on the basis of the following criteria:
accuracy of medical records concerning SAP performed; presence of indications to perform SAP according to LG; appropriateness of AMA selection; exact time and route of administration of AMA relative to the start of the surgical intervention; length of AMA administration.
On the basis of these criteria, SAP was assessed as good, satisfactory, or not good using the three-level scale. Good grade was given when all criteria of LG were satisfied: administration of SAP when indicated, adequate AMA selection administered in an appropriate dose, dose regimen and length of administration as well as when the medical records were appropriately completed. Satisfactory grade was awarded when there were minor deviations from LG: e.g., prescribing suboptimal AMA, administration of additional and unnecessary AMA doses according to LG within up to 48 hours, as well as some omissions in the medical records. Not good grade was awarded when AMA was inappropriately selected, when AMA was administered for the purpose of prophylaxis without reason or when no AMA were administered for the purpose of prophylaxis when there were indications for such administration, when the length of SAP was more than 48 hours as well as for major omissions in the medical records. The ratio between appropriately and inappropriately performed SAP was calculated from the ratio of the sum of good and satisfactory grades and the sum of not good grades.
The feedback to the Surgery Clinic Management assumed written reports of the clinical pharmacologists at monthly intervals about the results of the completed monitoring.
The assessment of AMA usage was performed using the defined daily dose method: (DDD/100 patient days) which is an appropriate statistical measure of total drug use in a hospital [24] . Annual AMA costs were reported for the three-year period (2008) (2009) (2010) . For that purpose, the computerized database of the hospital pharmacy and the results from the hospital statistical unit about the number of beds at the Surgery Clinic and their average yearly occupancy were used and the calculations were performed by means of ABC Calc Version 3.1 [25] .
RESULTS
The results of this study covered a three-year period of assessment of SAP and AMA use at the Surgery Clinic. Three months after the imple-mentation of LG for SAP, the level of appropriately performed SAP increased from 5% to 40%. The upward trend continued with some fluctuations during the subsequent months as well: at month 8, 12, and 16 of the LG implementation, the level of rationally performed SAP increased o 64%, 79%, and 92%, respectively. Table 1 shows the results of 4 monitorings of SAP carried out at the Surgery Clinic within 16 months of the implementation of LG for SAP.
The increased level of rational performance of SAP was also accompanied by considerable reduction in AMA usage at the Clinic presented through the DDD/100 patient day parameter. 
DISCUSSION
SAP is a method proved to be effective in reducing the risk of SSI. It is known, however, that As the result of comprehensive measures taken at the end of 2009, SAP was rationally performed in more than 90% and by this parameter the Surgery Clinic ranked among the world leading surgery clinics. The rational performance of SAP was associated with the significant reduction in AMA usage in 2009 compared to 2008, which in turn led to direct economic benefits -there was a considerable saving of financial resources as well.
Upon development and implementation of LG for SAP, some weaknesses such as the use of third-generation cephalosporins have still maintained relatively high and the acceptable length of SAP up to 48 hours in high-risk patients have not been fully resolved yet. In addition, merging the good and satisfactory grades could be also seen as a compromise in the assessment of the appropriateness of performed SAP. This was done mainly to avoid excessively rigid approach in SAP assessment as well as to encourage the compliance of the surgical team. A similar approach in SAP assessment has been also adopted by other authors [26] .
This study is a pilot project carried out by the University Surgery Clinic in Sofia and does not claim to be exhaustive. Regardless of the joint efforts made by the clinical pharmacologists and the Management of the Surgery Clinic, it took more than one year of the implementation of LG for SAP before achieving an optimal result. In our opinion, this was due to some initial underestimation of the problem with the rational performance of SAP by the surgical team, certain reluctance to take up additional paperwork in connection with documentation of SAP as well as the lack of effective incentives to the surgical team introduced by the Management of the Hospital. Regardless of the remarks that can be made in respect of individual aspects of this project, its effective implementation in the clinical practice as well as the achieved economic results convincingly demonstrated the benefits of the interdisciplinary approach in the development and implementation of LG for SAP. The effectiveness of such approach has been also demonstrated in other studies [27, 28, 29] .
CONCLUSIONS
In order to extend the scope of this project, LG for SAP are planned to be adapted and imple- 
